| 1990 |
XRN1 encodes a 5'→3' exoribonuclease in yeast; disruption of the gene is not lethal but markedly reduces cell growth rate, which is rescued by reintroduction of XRN1 on a plasmid. |
Gene disruption (knockout) in haploid yeast, complementation with plasmid-borne XRN1, poly(A) hydrolytic activity assay, immunoreactivity |
Gene |
High |
1979303
|
| 1992 |
XRN1 (also known as DST2/SEP1/KEM1/RAR5) encodes a 160-kDa 5'→3' exoribonuclease; xrn1-deleted yeast cells show 2–4-fold longer half-lives of specific short-lived mRNAs, increased cellular protein levels, and reduced rRNA synthesis rate, demonstrating XRN1's key role in mRNA turnover. |
Gene sequencing, gene disruption, Northern analysis of specific mRNA half-lives, metabolic labeling, PAGE analysis |
Gene |
High |
1398123
|
| 1991 |
The SEP1 (XRN1) protein promotes homologous DNA pairing (strand exchange) in vitro and is required in meiosis; sep1 mutants show reduced meiotic recombination and defective sporulation, with arrest after commitment to recombination but before meiosis I. |
Gene cloning, protein overproduction and purification, in vitro strand exchange assay, mutant phenotype analysis (sporulation, recombination) |
Molecular and cellular biology |
High |
1840632
|
| 1993 |
XRN1/KEM1 encodes the major cytoplasmic 5'→3' exoribonuclease (p175); its essential nuclear paralog HKE1/RAT1 encodes a related 5'→3' exoribonuclease (p116); overexpression of XRN1 p175 cannot rescue loss of HKE1/RAT1, indicating non-redundant functions. |
Gene cloning, in vitro 5'→3' exoribonuclease activity assay, immunodepletion, complementation test |
Molecular and cellular biology |
High |
8417335
|
| 1994 |
Sep1 (XRN1) promotes paranemic joint formation between homologous DNA molecules in vitro; the pairing does not require net intertwining and requires as little as 41 bp of homology; the exonuclease activity of Sep1 is not responsible for the joint. |
Nitrocellulose filter binding assay, electron microscopy, in vitro DNA pairing with defined substrates, exonuclease activity controls |
Genes & development |
High |
7926736
|
| 1995 |
Sep1/Xrn1 is an abundant cytoplasmic protein (~80,000 molecules/diploid cell); >90% is cytoplasmic by cell fractionation and indirect immunofluorescence, supporting a role in cytoplasmic RNA metabolism rather than nuclear processes. |
Cell fractionation, indirect immunofluorescence, quantitative immunoblot |
Molecular and cellular biology |
High |
7739553
|
| 1995 |
sep1 (xrn1) ski2 and sep1 (xrn1) ski3 double mutants are synthetically lethal in a manner independent of killer viruses, and sep1 ski2/ski3 double mutants arrest in late G1 at Start; this places XRN1 and the SKI complex in parallel pathways controlling translation on transcripts targeted for degradation. |
Genetic epistasis, synthetic lethality screen, temperature-sensitive allele analysis, cell cycle arrest characterization |
Molecular and cellular biology |
High |
7739552
|
| 1995 |
Sep1/Xrn1 promotes polymerization of porcine brain and yeast tubulin into microtubules in vitro and co-sediments with microtubules; sep1 mutants show increased benomyl sensitivity, chromosome loss, karyogamy defect, and impaired spindle pole body separation; genetic interaction with tubulin genes supports a role as a microtubule-associated protein. |
In vitro tubulin polymerization assay, sucrose cushion co-sedimentation, benomyl sensitivity assay, genetic double mutants with tubulin genes |
The EMBO journal |
High |
7720696
|
| 1995 |
N-terminal sequences of Sep1/Xrn1 are essential for complementing slow growth and benomyl hypersensitivity, while at least 270 C-terminal amino acids are dispensable; the essential sequences correspond to regions conserved with the S. pombe Exo2 homolog. |
N- and C-terminal deletion analysis, plasmid complementation of null mutant |
Chromosoma |
Medium |
8529461
|
| 1995 |
sep1 mutants arrest in pachytene during meiotic prophase with normal synaptonemal complex; the arrest is RAD9-independent; sep1 is deficient in meiotic double-strand break repair, and sep1 dmc1 and sep1 rad51 double mutants virtually eliminate pop-out recombination, indicating parallel recombination pathways. |
Electron microscopy of meiotic spreads, physical assay of recombination intermediates, genetic epistasis with rad51/dmc1 |
Genetics |
High |
7713413
|
| 1997 |
XRN1 5'→3' exoribonucleolytic hydrolysis is stalled by oligo(G) tracts and strong secondary structures in RNA; poly(A) binding protein inhibits XRN1 hydrolysis of poly(A) but does not affect the related HKE1; stem-loop structures near the 5' end cause greater inhibition of HKE1 than XRN1. |
In vitro 5'→3' exoribonuclease assay with defined RNA substrates containing secondary structures, protein competition experiments |
Biochemical and biophysical research communications |
High |
9207242
|
| 1998 |
Human XRN1 (hSEP1) protein is localized in the cytoplasm, as determined by cytochemical analysis and Western blot of fractionated cellular extracts. |
Subcellular fractionation, Western blot, cytochemical analysis |
DNA research |
Medium |
9802570
|
| 2000 |
Genetic synthetic lethality between xrn1Δ and cdc33 (eIF4E) or ceg1 (guanylyltransferase) mutations indicates that XRN1-mediated mRNA turnover pathway is functionally linked to proper mRNA capping and eIF4E–eIF4G interaction; blocking XRN1 enhances the requirement for 7mG caps and cap-recognition complex. |
Synthetic lethality screen, genetic epistasis, high-copy suppression analysis |
Genetics |
Medium |
10790382
|
| 2004 |
The C. elegans 5'→3' exoribonuclease xrn-1 is required for ventral epithelial enclosure during embryogenesis; RNAi knockdown of xrn-1 results in failure of epithelial closure, establishing a role for the 5'→3' mRNA decay pathway in morphogenesis. |
RNAi knockdown of xrn-1 in C. elegans, embryonic phenotype analysis |
RNA (New York, N.Y.) |
Medium |
14681585
|
| 2005 |
In Drosophila cells, 3' mRNA fragments generated by RISC cleavage are degraded from their 5' ends by XRN1, while 5' fragments are degraded by the exosome; this establishes XRN1 as the nuclease responsible for degrading the 3' products of siRNA-directed cleavage. |
RNAi depletion of XRN1 and exosome components in Drosophila S2 cells, RNA blot detection of RISC cleavage intermediates |
RNA (New York, N.Y.) |
High |
15703439
|
| 2008 |
XRN1 (along with Rat1) is a component of the rapid tRNA decay (RTD) pathway that degrades hypomodified mature tRNA species in yeast; deletion of XRN1 and RAT1 prevents both degradation and deacylation of hypomodified tRNA(Val(AAC)) and rescues temperature-sensitive growth. |
Genetic deletion of XRN1, RAT1, and MET22 in trm8Δ trm4Δ strains, Northern blot for tRNA levels, aminoacylation assays, growth phenotype analysis |
Genes & development |
High |
18443146
|
| 2008 |
The 20S RNA narnavirus 5'-end strong secondary structure (G-rich, buried stem) enables it to evade SKI1/XRN1-mediated degradation; mutations that weaken this structure make the virus vulnerable to XRN1, demonstrating that RNA secondary structure at the 5' end is the molecular basis of XRN1 resistance. |
XRN1 overexpression and deletion in yeast, mutational analysis of viral 5'-stem structure, viral copy number measurement |
The Journal of biological chemistry |
High |
18640978
|
| 2010 |
An RNA pseudoknot (PSK3) in the yellow fever virus 3' UTR is required for stalling the host XRN1 exonuclease and producing sfRNA; the pseudoknot was confirmed by structure probing and mutagenesis; the stalling element alone is sufficient to direct sfRNA-like RNA production from a heterologous vector. |
In vitro XRN1 degradation assay with purified XRN1, RNA structure probing, mutagenesis, 5' end sequencing of sfRNA, heterologous expression |
Journal of virology |
High |
20739539
|
| 2011 |
Crystal structure of Xrn1 in complex with a substrate reveals that the 5'-terminal trinucleotide stacks between aromatic side chains while a highly basic pocket specifically recognizes the 5' phosphate; mutations in residues binding the 5'-terminal nucleotide impair Xrn1 processivity; the mechanism couples processive hydrolysis to duplex melting for substrates with single-stranded 5' overhangs. |
X-ray crystallography of Xrn1–substrate complex, site-directed mutagenesis of binding residues, in vitro processivity and activity assays |
Molecular cell |
High |
21362555
|
| 2011 |
Crystal structure of Kluyveromyces lactis Xrn1 (residues 1–1245, E178Q mutant) shows that the two conserved XRN regions form the active site, and that a unique 510-residue segment (absent from Rat1/Xrn2) contains four domains (D1–D4) that stabilize the N-terminal segment conformation and likely serve as a platform for protein partners; mutagenesis confirms functional importance of D1–D4 for activity. |
X-ray crystallography, site-directed mutagenesis, in vitro biochemical activity assays |
Nature structural & molecular biology |
High |
21297639
|
| 2011 |
XRN1 is recruited to translating mRNAs following SOX-induced internal cleavage by the Kaposi's sarcoma-associated herpesvirus host shutoff factor, and degrades the resulting fragments; SOX co-sediments with translation initiation complexes and cleaved intermediates accumulate in the 40S fraction, indicating XRN1 degrades mRNAs during translation. |
Polysome sedimentation, RNA blot detection of cleavage intermediates, XRN1 depletion, co-sedimentation analysis |
PLoS pathogens |
Medium |
22046136
|
| 2012 |
XRN1 directly interacts with DCP1 in Drosophila cells and with EDC4 in human cells, coupling mRNA decapping to 5'→3' degradation; the interaction is mediated by the DCP1 EVH1 domain binding a DCP1-binding motif (DBM) in XRN1's C-terminal region, as revealed by NMR structure. |
Co-immunoprecipitation, NMR structure of DCP1 EVH1 domain bound to XRN1 DBM peptide, in vivo interaction mapping |
Nature structural & molecular biology |
High |
23142987
|
| 2012 |
Flavivirus sfRNA formation inhibits XRN1 activity in Dengue- and Kunjin virus-infected cells; XRN1 repression results in accumulation of uncapped mRNAs and increased overall cellular mRNA stability; a mutant Kunjin virus unable to form sfRNA does not affect host mRNA stability or XRN1 activity. |
Viral infection with sfRNA-null mutant virus, sfRNA expression in absence of infection, XRN1 activity assays, mRNA stability measurements, detection of uncapped mRNA intermediates |
RNA (New York, N.Y.) |
High |
23006624
|
| 2012 |
HCV RNA replication is degraded primarily by XRN1 in infected cells; XRN1 knockdown enhances HCV replication and miR-122 supplementation and XRN1 knockdown have equal, redundant, nonadditive effects on viral RNA decay, indicating miR-122 protects HCV RNA specifically from XRN1-mediated 5' decay. |
XRN1 siRNA knockdown, miR-122 supplementation, viral RNA decay assays, sequencing of 5' and 3' RNA degradation intermediates in infected cells |
Proceedings of the National Academy of Sciences of the United States of America |
High |
23248316
|
| 2012 |
Dcs1 (scavenger decapping enzyme) functions as a specific cofactor of Xrn1 in yeast: Dcs1 improves the apparent affinity of Xrn1 for RNA and forms a complex with Xrn1 in vitro; Xrn1 is essentially inactive in the absence of Dcs1 in vivo; this activation is required for mitochondrial respiration (growth on glycerol). |
In vitro RNA binding and exoribonuclease assays with purified proteins, co-IP, in vivo growth assays, 2D protein gel analysis of deletion strains |
Proceedings of the National Academy of Sciences of the United States of America |
High |
22570495
|
| 2013 |
Global mRNA level buffering in yeast requires Xrn1: in strains lacking mRNA degradation factors, changes in degradation rates are compensated by changes in synthesis rates, but this buffering is abolished in xrn1Δ strains, indicating Xrn1 is required for the feedback coupling between mRNA decay and transcription. |
Comparative dynamic transcriptome analysis (cDTA) with metabolic RNA labeling in 46 yeast mutant strains |
Molecular cell |
High |
24119399
|
| 2014 |
Dengue virus sfRNA is produced by XRN1 loading at the 5' end of genomic RNA and processively degrading ~10 kb, stalling at two independently-folded RNA structures organized around a three-way junction; disrupting the junction's fold eliminates sfRNA production in human cells infected with flavivirus. |
Real-time in vitro XRN1 resistance assay, RNA mutagenesis, RNA folding analysis, cell-based sfRNA detection in flavivirus-infected human cells |
eLife |
High |
24692447
|
| 2015 |
XRN1 depletion in vaccinia virus-infected cells leads to accumulation of double-stranded RNA (dsRNA) and activation of PKR and OAS/RNase L innate immune effectors; XRN1 is therefore a cellular factor regulating dsRNA accumulation and dsRNA-responsive innate immunity, and is required for VacV growth. |
siRNA depletion of XRN1 in VacV-infected cells, dsRNA quantification, PKR and OAS pathway activation assays, viral growth assays |
Cell host & microbe |
High |
25766294
|
| 2015 |
XRN1 co-localizes with post-synaptic structures in neurons as discrete 'synaptic XRN1 bodies' (SX-bodies) distinct from P-bodies or stress granules; NMDA receptor stimulation increases SX-body size and number while decreasing local translation, and XRN1 knockdown impairs NMDA-triggered translational repression. |
Fluorescence microscopy in primary neurons, XRN1 siRNA knockdown, synaptic stimulation assays (NMDA, mGluR), local translation measurements |
Journal of cell science |
Medium |
25736288
|
| 2015 |
In Drosophila, null mutation in pacman/xrn1 increases expression of pro-apoptotic mRNAs hid and reaper at the post-transcriptional level; the null phenotype (small imaginal discs, pupal lethality) is rescued by deletion removing one copy of reaper/hid/grim, placing Pacman/XRN1 in the apoptotic pathway by targeting these mRNAs for degradation. |
Drosophila genetic null mutation, rescue by pro-apoptotic gene deletion, quantitative RT-PCR of hid and reaper mRNAs, pre-mRNA analysis to confirm post-transcriptional regulation |
Biology open |
High |
25836675
|
| 2015 |
Xrn1 accumulates at plasma membrane-associated eisosomes after glucose exhaustion (post-diauxic shift) in yeast, dependent on eisosome components Pil1 and Sur7; this sequestration is not accompanied by other mRNA-decay machinery components and Xrn1 is released from eisosomes by glucose addition. |
Fluorescence microscopy of GFP-tagged Xrn1, genetic deletion of PIL1 and SUR7, glucose addition experiments |
PloS one |
Medium |
25811606
|
| 2017 |
Yeast Pat1 C-terminal region directly interacts with a helical leucine-rich motif (HLM) in the C-terminal region of yeast Xrn1, as revealed by structural analysis of Pat1-HLM complexes; this interaction surface also recruits Dcp2, and ability to bind HLMs is required for efficient growth and normal mRNA decay. |
Co-immunoprecipitation, X-ray crystallography of Pat1-HLM complex, in vivo mRNA decay assays, growth assays |
Proceedings of the National Academy of Sciences of the United States of America |
High |
29078363
|
| 2017 |
Xrn1 sequestration at eisosomes during post-diauxic shift in yeast inhibits Xrn1-mediated mRNA degradation; eisosome-associated Xrn1 retains its enzymatic functionality and is re-activated upon glucose addition; cells lacking eisosome organizer Pil1 retain Xrn1 mRNA decay activity into stationary phase. |
mRNA decay assays in wild-type and pil1Δ strains, glucose addition experiments, Xrn1 localization tracking |
European journal of cell biology |
Medium |
28501103
|
| 2017 |
Xrn1 physically interacts with the Gag protein of the L-A totivirus in S. cerevisiae, and XRN1 has evolved under positive natural selection in Saccharomyces with sequence differences that translate to species-specific antiviral activity against cognate L-A viruses. |
Co-immunoprecipitation of Xrn1 with L-A Gag protein, phylogenetic analysis of positive selection, cross-species complementation experiments with different Xrn1 orthologs |
PLoS pathogens |
Medium |
27711183
|
| 2017 |
RNA structures in the 3'-terminal portion of the Rift Valley fever virus N mRNA and in ambisense transcripts of arenaviruses can stall and repress XRN1; the phlebovirus stalling element likely forms a G-quadruplex structure. |
In vitro XRN1 stalling biochemical assays, mutagenesis, G-quadruplex prediction |
The Journal of biological chemistry |
Medium |
29118186
|
| 2017 |
Xrn1 promotes ssDNA generation at uncapped telomeres and is necessary for DNA damage checkpoint activation upon telomere uncapping; Xrn1 also maintains telomere length by promoting Cdc13 association with telomeres independently of ssDNA generation, and downregulates the Rif1 telomerase-inhibitor transcript. |
Genetic deletion of XRN1, telomere length assays, checkpoint activation assays, ChIP for Cdc13 association, RNA levels analysis |
Nucleic acids research |
Medium |
28160602
|
| 2018 |
The m6A reader YTHDC2 directly interacts with XRN1 via its ankyrin repeat domains in an RNA-independent manner; this interaction recruits XRN1 to m6A-containing mRNAs, promoting their degradation, while the YTH and R3H domains of YTHDC2 also contribute to RNA binding. |
Co-immunoprecipitation (RNA-independent conditions), domain mapping (ankyrin repeat deletions), CRAC analysis, YTH domain binding assay |
RNA (New York, N.Y.) |
High |
29970596
|
| 2018 |
The DNA damage checkpoint kinase Rad53 directly phosphorylates Xrn1 in vitro; Xrn1 was the most enriched substrate in a phosphoproteomic screen for Rad53 targets; phosphorylation of Xrn1 by Rad53 does not affect Xrn1's intrinsic nuclease activity in vitro but may affect activity or specificity in vivo. |
Mass spectrometry-based phosphoproteomic screen, in vitro kinase assay with Rad53 and Xrn1, in vitro nuclease activity assay |
G3 (Bethesda, Md.) |
Medium |
30377154
|
| 2018 |
XRN1 is a post-transcriptional negative regulator of autophagy in both yeast and mammalian cells; XRN1 deletion in yeast enhances autophagy and upregulates ATG transcripts via its ribonuclease activity; in mammalian cells, XRN1 siRNA depletion enhances autophagy and picornavirus replication. |
Chromosomal deletion of XRN1, autophagy assays (autophagosome formation), ATG transcript level measurement, catalytic mutant analysis, siRNA depletion in mammalian cells |
Autophagy |
Medium |
29465287
|
| 2019 |
Cryo-EM structure of the S. cerevisiae 80S ribosome–Xrn1 complex reveals that Xrn1 binds at the mRNA exit site of the ribosome via its conserved core; mRNA is channelled directly from the ribosomal decoding site into the Xrn1 active center, separated by only 17 ± 1 nucleotides, enabling co-translational mRNA decay. |
Cryo-electron microscopy structure determination of programmed 80S ribosome–Xrn1 complex |
Nature structural & molecular biology |
High |
30911188
|
| 2019 |
A low-complexity C-terminal region of human XRN1 (CIR) directly interacts with the CCR4-NOT deadenylase complex and with the decapping activator PatL1; CIR overexpression represses reporter mRNA deadenylation in human cells and inhibits CCR4-NOT and CAF1 deadenylase activity in vitro; PatL1 binding to CIR alleviates CIR-mediated inhibition of CCR4-NOT. |
In vitro deadenylase activity assay with purified proteins, reporter mRNA deadenylation assay in XRN1-null cell line complementation, direct binding assays |
Nucleic acids research |
High |
31340047
|
| 2019 |
Xrn1 promotes translation of a specific group of transcripts encoding membrane proteins via interactions with components of the translation initiation machinery and correlates with Xrn1-dependence for mRNA localization at the endoplasmic reticulum; for this group, Xrn1 stimulates transcription, mRNA translation, and decay. |
Transcriptome-wide ribosome profiling, polysome analysis, ER fractionation, biochemical interaction studies with translation initiation factors |
Nature communications |
Medium |
30899024
|
| 2019 |
Xrn1 modulates RNA polymerase II (Pol II) transcription initiation and elongation; NET-seq in xrn1Δ yeast shows reduced Pol II occupancy downstream of transcription start sites and increased Pol II accumulation near cleavage/polyadenylation sites with features of backtracked Pol II; Xrn1 functions mainly as a transcriptional activator. |
Native elongating transcript sequencing (NET-seq), mathematical modeling of transcription rates in xrn1Δ yeast |
The Journal of biological chemistry |
Medium |
32518159
|
| 2020 |
Xrn1 biochemically associates with eisosomal proteins specifically after the post-diauxic shift in yeast but not during exponential growth; decapping complex and Lsm1-7/Pat1 complex do not associate with eisosomal proteins under the same conditions, indicating selective sequestration of Xrn1. |
Tandem affinity purification (TAP) and mass spectrometry in different growth phases, biochemical co-purification |
microPublication biology |
Medium |
37746059
|
| 2021 |
Xrn1 is a NAD cap decapping (deNADding) enzyme: it releases intact NAD from NAD-capped RNAs and subsequently degrades the RNA; a deNADding-deficient Xrn1 mutant that retains 5'-monophosphate exonuclease activity reveals that Xrn1 deNADding is required for normal growth on non-fermenting sugar and modulates mitochondrial NAD-capped RNA levels. |
In vitro NAD cap decapping assay with Xrn1, deNADding-deficient point mutant generation, growth phenotype analysis on glycerol, mitochondrial RNA fractionation and analysis |
Nature communications |
High |
35173156
|
| 2021 |
Measles virus (MeV) hijacks XRN1 by translocating it to cytoplasmic inclusion bodies (IBs) where viral replication occurs; XRN1 at IBs degrades dsRNA, suppressing PKR-ISR pathway activation and facilitating viral replication; XRN1 knockout increases dsRNA accumulation, PKR activation, and suppresses MeV replication. |
Immunofluorescence localization of XRN1 in MeV-infected cells, XRN1 knockout, dsRNA immunofluorescence, PKR phosphorylation assays, viral replication assays |
Journal of virology |
Medium |
36300942
|
| 2021 |
XRN1 directly interacts with NS1 protein of influenza A virus (IAV) and co-localizes with NS1 in P-bodies; XRN1 suppresses RIG-I-mediated IFN-β production; XRN1 depletion impairs viral replication and enhances innate immune response, while overexpression increases viral titers. |
Co-immunoprecipitation of XRN1 and NS1, co-localization immunofluorescence, XRN1 knockdown/knockout and overexpression, IFN-β mRNA and p-IRF3 quantification, viral titer assays |
mBio |
Medium |
34311580
|
| 2022 |
The 3'→5' RNA helicase activity of YTHDC2 is essential for mouse fertility; this helicase activity is enhanced by YTHDC2's interaction with XRN1; loss of helicase activity (catalytic-dead mutant, dominant negative) causes infertility with mixed mitotic/meiotic transcriptome identity in germ cells. |
Mouse genetic knockin of catalytic-dead YTHDC2 helicase mutation, biochemical in vitro helicase assay with and without XRN1, single-cell transcriptomics, zebrafish ythdc2 mutant analysis |
Molecular cell |
High |
35305312
|
| 2023 |
Disrupting the EDC4–XRN1 interaction or altering their stoichiometry in human cells inhibits mRNA decapping and stabilizes microRNA-targeted mRNAs in a translationally repressed state; this leads to larger P-bodies that prevent mRNA decapping; P-bodies support cell viability and prevent stress granule formation when XRN1 is limiting. |
Disruption of EDC4-XRN1 interaction (domain mutants), reporter mRNA decay assays, P-body size/number quantification by microscopy, stress granule formation assay, XRN1-null cell line complementation |
The EMBO journal |
High |
37621215
|
| 2024 |
XRN1 depletion activates the dsRNA sensor RIG-I/MAVS pathway and IFN signaling by causing accumulation of cytosolic dsRNA from endogenous retroelements (Alus); XRN1 is an essential gene for survival of a subset of cancer cells with high ISG expression, and this dependency is mediated by PKR and MAVS signaling. |
CRISPR-based XRN1 deletion in cancer cell lines, dsRNA quantification, RIG-I/MAVS knockdown epistasis, pan-cancer CRISPR screen analysis, dsRNA-inducing drug combination |
Cell reports |
Medium |
38261511
|
| 2024 |
XRN1 deletion causes PKR pathway activation and cancer cell lethality in cells with high interferon-stimulated gene (ISG) expression; XRN1 depletion causes accumulation of endogenous complementary sense/anti-sense RNAs as candidate PKR ligands; JAK1/2 inhibition (reducing PKR levels) rescues sensitivity to XRN1 deletion. |
XRN1 CRISPR deletion, PKR pathway activation assays, ruxolitinib rescue experiment, IFN-β stimulation sensitization experiment, endogenous dsRNA sequencing |
Cell reports |
Medium |
38261514
|